Predictive performance of machine learning compared to statistical methods in time-to-event analysis of cardiovascular disease: a systematic review protocol
Open Access
Abstract
Background Globally, cardiovascular disease (CVD) remains the leading cause of death, warranting effective management and prevention measures. Risk prediction tools are indispensable for directing primary and secondary prevention strategies for CVD and are critical for estimating CVD risk. Machine learning (ML) methodologies have experienced significant advancements across numerous practical domains in recent years. Several ML and statistical models predicting CVD time-to-event outcomes have been developed. However, it is not known as to which of the two model types—ML and statistical models—have higher discrimination and calibration in this regard. Hence, this planned work aims to systematically review studies that compare ML with statistical methods in terms of their predictive abilities in the case of time-to-event data with censoring. Methods Original research articles published as prognostic prediction studies, which involved the development and/or validation of a prognostic model, within a peer-reviewed journal, using cohort or experimental design with at least a 12-month follow-up period will be systematically reviewed. The review process will adhere to the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies checklist. Ethics and dissemination Ethical approval is not required for this review, as it will exclusively use data from published studies. The findings of this study will be published in an open-access journal and disseminated at scientific conferences. PROSPERO registration number CRD42023484178.Keywords
Funding Information
- College of Graduate Studies, United Arab Emirates University
This publication has 22 references indexed in Scilit:
- Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligenceBMJ Open, 2021
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplarBMJ, 2020
- Machine learning prediction in cardiovascular diseases: a meta-analysisScientific Reports, 2020
- Cardiovascular disease risk prediction models: challenges and perspectivesThe Lancet Global Health, 2019
- Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015JACC, 2017
- Risk scoring for the primary prevention of cardiovascular diseaseCochrane Database of Systematic Reviews, 2017
- A guide to systematic review and meta-analysis of prediction model performanceBMJ, 2017
- The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)Clinical Science, 2001
- A neural network model for survival dataStatistics in Medicine, 1995